succinylacetone has been researched along with CKD-MBD in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Succinylacetone in urine was elevated in both, 30 and 79 mumol/mmol creatinine, respectively." | 1.28 | Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction. ( Halvorsen, S; Kvittingen, EA; Steen-Johnsen, J; Søvik, O, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Søvik, O | 1 |
| Kvittingen, EA | 1 |
| Steen-Johnsen, J | 1 |
| Halvorsen, S | 1 |
1 other study available for succinylacetone and CKD-MBD
| Article | Year |
|---|---|
Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids; Child; Child, Preschool; Chronic Kidn | 1990 |